Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vision training may boost brain and body health in intellectual disability

NCT ID NCT06628999

Knowledge-focused Sponsor: Università degli Studi dell'Insubria Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if a 16-week perceptual-vision training program could improve thinking skills (like focus) and physical fitness (balance, strength, agility) in adults aged 40-70 with mild intellectual disability. Participants were to be split into training, training-then-rest, and control groups. However, the study was withdrawn before enrolling anyone, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

May 2025

An estimate. Start dates often move.

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age between 40 and 70 years * mild ID (Intellectual Quotient = 51-69). Exclusion Criteria: * inability to understand basic verbal communication * strict dependence on personnel or assistive support devices * presence of concomitant sensorial or physical impairments * presence of behavioural problems or any other clinical condition that may compromise the regular physical activity practice

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Activity, motor are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intellectual disability Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Activity, motor Intellectual disability Intellectual impairment Sports physical therapy

More trials for these conditions

Other studies related to the condition(s) this trial covers.